Cronos Group Inc Stock News

The cannabis industry continues to demonstrate why it deserves the same opportunities as other legitimate businesses. From an investment side, there are many who have put up big money in various global regions to be a part of this booming industry. Places like Canada and the USA are where the main markets exist. Now there are several parts to this, both bitter and sweet. Here is why it could be...

Bitcoin, Ethereum and other cryptocurrencies were reacting to hopes of interest-rate cuts while President Donald Trump's family is backing smaller crypto Cronos.

Investors are closely watching the US cannabis space after President Donald Trump signaled plans to reschedule marijuana, a move that is expected to unlock near-term financial relief and longer-term growth for the industry. Trump recently stated that his administration will “be moving forward soon with rescheduling marijuana,” referring to its reclassification as a lower-risk Schedule III drug.

In the last 3-6 months, most marijuana stocks have gone from bottom prices to an upward swing. For a long while, the sector has fallen and lain dormant. This led to much fear and doubt among some shareholders. Even with the continued progress of the cannabis industry as a whole, it is only as of August 2025 that marijuana is waking back up. Now, for places like Canada, they have their own issue...

Marijuana stocks have begun to gain traction in trading, exhibiting moderate consistency. But why did this occur, and what is happening to bring such momentum to the sector? Once again, the backing and favorable side of passing federal reform for cannabis is being discussed by top politicians. In recent talks, President Donald Trump voiced his stance on cannabis and how it should be legalized u...

Cannabis stocks rallied today over news of possible rescheduling by the Trump administration. Even though Cronos Group Inc. does not have a U.S. entry strategy, its stock price was up 15% on the news. Cronos reported improved financial performance last Thursday with higher revenues and improved international sales.

Cannabis stocks moved sharply higher on reports that President Donald Trump is considering rescheduling marijuana to a less restrictive drug category. The move would see marijuana reclassified from a Schedule I drug, along with heroin and cocaine, to Schedule III.

Following a Wall Street Journal report, cannabis stocks surged Monday due to speculation that US President Donald Trump is considering reclassifying marijuana to a lower danger level. Canopy Growth and Tilray Brands both saw surges of over 12% on Monday.